Selective 5-HT2C receptor agonists: Design and synthesis of pyridazine-fused azepines

被引：5
作者：
Green, Martin P. [1 ]
McMurray, Gordon [2 ]
Storer, R. Ian [1 ]
机构：
[1] Sandwich Labs, Pfizer Global Res & Dev, Worldwide Med Chem, Sandwich CT13 9NJ, Kent, England
[2] Sandwich Labs, Pfizer Global Res & Dev, Discovery Biol, Sandwich CT13 9NJ, Kent, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2016年 / 26卷 / 16期
关键词：
5-HT2C receptor agonists; CNS penetration; Obesity; Pyridazino[3,4-d]azepines; Urinary incontinence; P-GLYCOPROTEIN; IN-VITRO; LORCASERIN; DISCOVERY; POTENT; DRUGS; PERMEABILITY; LIGANDS; OBESITY; CNS;
D O I：
10.1016/j.bmcl.2016.06.060
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Heterocycle-fused azepines are discussed as potent 5-HT2C receptor agonists with excellent selectivity over 5-HT2B agonism. Synthesis and structure activity relationships are outlined for a series of bicyclic pyridazino[3,4-d]azepines. By comparison with earlier published work, in vitro assays predict a high probability for achieving CNS penetration for a potent and selective compound 15a, a pre-requisite to achieve in vivo efficacy. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4117 / 4121
页数：5
相关论文
共 38 条
  • [1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension
    Abenhaim, L
    Moride, Y
    Brenot, F
    Rich, S
    Benichou, J
    Kurz, X
    Higenbottam, T
    Oakley, C
    Wouters, E
    Aubier, M
    Simonneau, G
    Begaud, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) : 609 - 616
  • [2] Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents
    Ahmad, Saleem
    Ngu, Khehyong
    Miller, Keith J.
    Wu, Ginger
    Hung, Chen-pin
    Malmstrom, Sarah
    Zhang, Ge
    O'Tanyi, Eva
    Keim, William J.
    Cullen, Mary Jane
    Rohrbach, Kenneth W.
    Thomas, Michael
    Ung, Thao
    Qu, Qinling
    Gan, Jinping
    Narayanan, Rangaraj
    Pelleymounter, Mary Ann
    Robl, Jeffrey A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1128 - 1133
  • [3] Design and synthesis of pyridazinone-based 5-HT2C agonists
    Allerton, Charlotte M. N.
    Andrews, Mark D.
    Blagg, Julian
    Ellis, David
    Evrard, Edel
    Green, Martin P.
    Liu, Kevin K. -C.
    McMurray, Gordon
    Ralph, Michael
    Sanderson, Vivienne
    Ward, Robin
    Watson, Lesa
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (19) : 5791 - 5795
  • [4] Andrews M. D., 2008, Preparation of pyrimido[4,5-d]azepine derivatives as 5-HT2C agonists, Patent No. [WO2008117169, 2008117169]
  • [5] Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence
    Andrews, Mark D.
    Fish, Paul V.
    Blagg, Julian
    Brabham, Tiffini K.
    Brennan, Paul E.
    Bridgeland, Alison
    Brown, Alan D.
    Bungay, Peter J.
    Conlon, Kelly M.
    Edmunds, Nicholas J.
    af Forselles, Kerry
    Gibbons, Colleen P.
    Green, Martin P.
    Hanton, Giles
    Holbrook, Mark
    Jessiman, Alan S.
    McIntosh, Karin
    McMurray, Gordon
    Nichols, Carly L.
    Root, James A.
    Storer, R. Ian
    Sutton, Michael R.
    Ward, Robin V.
    Westbrook, Dominique
    Whitlock, Gavin A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2715 - 2720
  • [6] Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT2c agonists
    Andrews, Mark D.
    Green, Martin P.
    Allerton, Charlotte M. N.
    Batchelor, David V.
    Blagg, Julian
    Brown, Alan D.
    Gordon, David W.
    McMurray, Gordon
    Millns, Daniel J.
    Nichols, Carly L.
    Watson, Lesa
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (18) : 5346 - 5350
  • [7] ABC transporters and the blood-brain barrier
    Begley, DJ
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (12) : 1295 - 1312
  • [8] Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence
    Brennan, Paul E.
    Whitlock, Gavin A.
    Ho, Danny K. H.
    Conlon, Kelly
    McMurray, Gordon
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (17) : 4999 - 5003
  • [9] Development of a New Permeability Assay Using Low-Efflux MDCKII Cells
    Di, Li
    Whitney-Pickett, Carrie
    Umland, John P.
    Zhang, Hui
    Zhang, Xun
    Gebhard, David F.
    Lai, Yurong
    Federico, James J., III
    Davidson, Ralph E.
    Smith, Russ
    Reyner, Eric L.
    Lee, Caroline
    Feng, Bo
    Rotter, Charles
    Varma, Manthena V.
    Kempshall, Sarah
    Fenner, Katherine
    El-Kattan, Ayman F.
    Liston, Theodore E.
    Troutman, Matthew D.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (11) : 4974 - 4985
  • [10] Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs
    Doan, KMM
    Humphreys, JE
    Webster, LO
    Wring, SA
    Shampine, LJ
    Serabjit-Singh, CJ
    Adkison, KK
    Polli, JW
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) : 1029 - 1037
1234